Clinical trial Recruiting at 1 site Interventional Ages 18 and up

MRI vs. pathology in bladder tumor staging

Official title: Tumor Staging T of Bladder Tumours: Correlation of MRI and Anatomopathologic Analysis.

Run by University Hospital, Clermont-Ferrand · NCT05464576 · Data updated 2026-11-12

This study tests whether MRI can reliably indicate bladder tumor stage before TURB in adults with confirmed bladder tumors.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment150 (estimated)
SponsorUniversity Hospital, Clermont-Ferrand
Academic / other
Locations1 site (Clermont-Ferrand)
StatusRecruiting
StartedSeptember 14, 2022
Main results expectedMarch 14, 2028
Study endsMarch 14, 2028
Registry record updatedSeptember 16, 2026
Trial IDNCT05464576 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults over 18 with a confirmed bladder tumor requiring TURB and able to read French.

Probably not a fit

Patients with contraindications to MRI or gadolinium contrast, or those not undergoing TURB, may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This single-center interventional study compares MRI findings to anatomopathology results from TURB in patients with newly diagnosed urinary bladder tumors. The goal is to see if MRI can accurately reflect tumor invasion level and potentially reduce reliance on invasive pathology for staging. Eligible participants are adults with bladder tumors confirmed by cystoscopy who are planned for TURB and can read French. MRI is performed with gadolinium contrast unless contraindicated, and results are compared to the gold-standard TURB pathology. The study builds on prior work suggesting MRI improvements may aid bladder cancer staging, aiming to improve diagnostic timing and patient management.

Why it matters

Potential benefit: If successful, MRI could improve preoperative staging accuracy and streamline patient care by informing treatment decisions earlier.

How similar studies have gone: Previous data suggest MRI can help assess bladder tumor invasion, but direct correlation with TURB pathology is still evolving and this study adds single-center validation.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patient, male or female, aged \>18ans
* Benefiting from Social Security
* Urinary bladder tumour confirmed on cystoscopy and requiring a TURB
* Understanding and reading French well
* Ability to give informed consent

Exclusion Criteria:

* Participation refusal
* MRI contraindication : pacemaker, heart valve, clips, stents, coils, non-MRI compatible defibrillators, neural or peripheral stimulator, cochlear implant, intraocular foreign body, claustrophobia
* Patient under guardianship, deprived of liberty, impaired understanding
* Pregnant/breastfeeding woman
* Allergy to gadolinium (contrast product necessary for carrying out the MRI), hypersensitivity to gadoteric acid or gadolinated contrast products, to meglumine
* Suspicion of an infectious disease such as schistosomiasis (differential diagnosis)
* Patient presenting with macroscopic clotting hematuria on the day of the MRI

Where it's running

  • CHU clermont-ferrand
    Clermont-Ferrand, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.